Surgery Partners, Inc. (SGRY) Stock Analysis
Recovery setup
Healthcare · Medical Care Facilities
Sell if holding. Engine safety override at $14.48: Quality below floor (3.5 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.9/10. Specifically: High short interest: 24%; Below-average business quality; Below long-term trend.
Surgery Partners owns and operates 176 surgical facilities (157 ASCs, 19 surgical hospitals) in 30 states generating ~$3.2B revenue from surgical facilities in 2025. Revenue is split ~43% government payors (Medicare/Medicaid) and ~52% private insurance.
Sell if holding. Engine safety override at $14.48: Quality below floor (3.5 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.9/10. Specifically: High short interest: 24%; Below-average business quality; Below long-term trend. Chart setup: Death cross but MACD improving, RSI 69. Score 4.9/10, moderate confidence.
Passes 5/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 4d<=7d. Suitability: aggressive.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHCustomerprivate insurance payors52%10-K Item 1A: 'Payments from private insurance payors...represented approximately 52%, 54% and 53% of our patient service revenue in 2025'
- MEDIUMCustomergovernment payors (Medicare and Medicaid)43%10-K Item 1A: 'We derived approximately 43%, 41% and 42% of our revenue from government payors, including Medicare and Medicaid programs in 2025'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
4 floor-breakers
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Unprofitable operations — net margin -2.4%. Quality floor flags this regardless of sector context.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $14.48: Quality below floor (3.5 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.9/10. Specifically: High short interest: 24%; Below-average business quality; Below long-term trend. Chart setup: Death cross but MACD improving, RSI 69. Prior stop was $13.43. Score 4.9/10, moderate confidence.
Take-profit target: $16.25 (+12.6% upside). Prior stop was $13.43. Stop-loss: $13.43.
Concentration risk — Customer: private insurance payors (52.0%); Quality below floor (3.5 < 4.0); Value-trap signals (2/5): High leverage (D/E 3.8), Material insider selling (3 sells, 13.77% of cap).
Surgery Partners, Inc. trades at a P/E of N/A (forward 36.1). TrendMatrix value score: 6.8/10. Verdict: Sell.
18 analysts cover SGRY with a consensus score of 4.1/5. Average price target: $19.
What does Surgery Partners, Inc. do?Surgery Partners owns and operates 176 surgical facilities (157 ASCs, 19 surgical hospitals) in 30 states generating...
Surgery Partners owns and operates 176 surgical facilities (157 ASCs, 19 surgical hospitals) in 30 states generating ~$3.2B revenue from surgical facilities in 2025. Revenue is split ~43% government payors (Medicare/Medicaid) and ~52% private insurance.